EcoDrugPlus

Indoleamine 2,3-Dioxygenase 1

Ensembl ID : ENSTBEG00000015688
Gene Symbol: IDO1
1 Cross references
98 Possible Orthologues:

Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta

Ensembl ID : ENSTBEG00000004801
Gene Symbol: IKBKB
1 Cross references
197 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 1

Ensembl ID : ENSTBEG00000013052
Gene Symbol: IMPDH1
1 Cross references
333 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 2

Ensembl ID : ENSTBEG00000011057
Gene Symbol: IMPDH2
1 Cross references
200 Possible Orthologues:

Insulin Like Growth Factor 1 Receptor

Ensembl ID : ENSTBEG00000012937
Gene Symbol: IGF1R
1 Cross references
274 Possible Orthologues:

Integrin Subunit Alpha 2b

Ensembl ID : ENSTBEG00000008566
Gene Symbol: ITGA2B
1 Cross references
189 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSTBEG00000007061
Gene Symbol: ITGA4
1 Cross references
236 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSTBEG00000006390
Gene Symbol: ITGB1
1 Cross references
299 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSTBEG00000015533
Gene Symbol: ITGB3
1 Cross references
265 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSTBEG00000000856
Gene Symbol: ITGB5
1 Cross references
210 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSTBEG00000015768
Gene Symbol: ITGB6
1 Cross references
206 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSTBEG00000001620
Gene Symbol: ITGB8
1 Cross references
202 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).